# NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy

> **NCT00535275** · PHASE3 · TERMINATED · sponsor: **Intergroupe Francophone de Cancerologie Thoracique** · enrollment: 88 (actual)

## Conditions studied

- Carcinoma, Non-Small-Cell Lung

## Interventions

- **DRUG:** Chemotherapy with platine
- **DRUG:** Chemotherapy without Cisplatine

## Key facts

- **NCT ID:** NCT00535275
- **Lead sponsor:** Intergroupe Francophone de Cancerologie Thoracique
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2007-09
- **Primary completion:** 2014-11
- **Final completion:** 2014-11
- **Target enrollment:** 88 (ACTUAL)
- **Why stopped:** Final analysis done, follow-up of patients no more necessary
- **Last updated:** 2015-02-16


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00535275

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00535275, "NSCLC Relapse Therapy After Surgery and Peri-operative Chemotherapy". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00535275. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*